Chronic Myelogenous Leukemia Treatment - NCI - National Cancer …
2023年11月17日 · Chronic myelogenous leukemia treatment may include targeted therapy, immunotherapy, chemotherapy, stem cell transplant, donor lymphocyte infusion, and/or surgery. Learn more about the diagnosis and treatment of CML in this expert-reviewed summary.
Chronic Myeloid Leukemia (CML): Symptoms, Treatment
2023年2月14日 · Chronic myeloid (myelogenous) leukemia (CML) is blood cancer that starts in the blood-forming myeloid cells or stem cells in your bone marrow. Healthcare providers treat CML with innovative therapies that have turned CML from being a potentially life-threatening illness into a chronic illness.
Treating Chronic Myeloid Leukemia - American Cancer Society
Treatment options for people with chronic myeloid leukemia (CML) depend on the phase of their disease (chronic, accelerated, or blast phase), their age, other prognostic factors, and the availability of a stem cell donor with matching tissue type.
Chronic myelogenous leukemia - Diagnosis and treatment - Mayo Clinic
2023年6月16日 · The goal of chronic myelogenous leukemia treatment is to eliminate the blood cells that contain the BCR-ABL gene. For most people, treatment begins with targeted therapy that may help achieve a long-term remission of the disease.
Chronic Myeloid Leukemia Treatment (PDQ®) - NCI
2024年12月13日 · Chronic myeloid leukemia treatments include tyrosine kinase inhibitors, high-dose therapy with allogeneic transplant, and other medications. Get detailed information about chronic myeloid leukemia (CML) treatment options in this summary for clinicians.
Treating Chronic Myeloid Leukemia by Phase - American Cancer Society
Treatment options for people with chronic myeloid leukemia (CML) depend on the phase of their disease (chronic, accelerated, or blast phase), their age and overall health, other prognostic factors, and the availability of a stem cell donor with a matching tissue type (for a …
Management of chronic myeloid leukemia in 2023 - Nature
2023年4月24日 · In the frontline therapy of CML in the chronic phase (CML-CP), imatinib and the three second-generation TKIs (bosutinib, dasatinib and nilotinib) are associated with comparable survival...
European LeukemiaNet 2020 recommendations for treating chronic myeloid ...
The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a normal life expectancy. Another goal is achieving a stable deep molecular response (DMR) and discontinuing medication for treatment-free remissio …
Chronic Myeloid Leukemia (CML) | Treatment by Phase of CML …
Tyrosine kinase inhibitor (TKI) therapy is standard treatment for chronic phase CML. TKIs are often successful at managing CML for long periods of time. The following TKIs are approved as primary treatment for chronic phase CML: After the start of therapy, doctors will monitor patients to determine how well a patient is responding to treatment.
How We Treat Chronic Myelogenous Leukemia - Dana-Farber …
Treatment of CML may include the following: Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Tyrosine kinase inhibitors (TKIs) are targeted therapy drugs often used as treatment for newly diagnosed patients with chronic phase CML.